222 related articles for article (PubMed ID: 33485844)
1. PCGF3 promotes the proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT signaling pathway.
Hu Y; Cheng Y; Jiang X; Zhang Y; Wang H; Ren H; Xu Y; Jiang J; Wang Q; Su H; Zhang B; Qiu X
Exp Cell Res; 2021 Mar; 400(2):112496. PubMed ID: 33485844
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
3. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
4. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
Fan X; Wu X
J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
[TBL] [Abstract][Full Text] [Related]
6. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
8. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
9. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
[TBL] [Abstract][Full Text] [Related]
10. Eupafolin regulates non-small-cell lung cancer cell proliferation,migration, and invasion by suppressing MMP9 and RhoA via FAK/PI3K/AKT signaling pathway.
Wang X; Huang M; Xie W; Ding Q; Wang T
J Biosci; 2023; 48():. PubMed ID: 36695419
[TBL] [Abstract][Full Text] [Related]
11. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.
Xia H; Li Y; Lv X
Int J Oncol; 2016 Oct; 49(4):1325-33. PubMed ID: 27498977
[TBL] [Abstract][Full Text] [Related]
13. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
[TBL] [Abstract][Full Text] [Related]
14. MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway.
Jiang J; Xu Y; Ren H; Wudu M; Wang Q; Song X; Su H; Jiang X; Jiang L; Qiu X
J Exp Clin Cancer Res; 2018 Aug; 37(1):189. PubMed ID: 30103781
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer.
Jian M; Yunjia Z; Zhiying D; Yanduo J; Guocheng J
Mol Carcinog; 2019 Mar; 58(3):358-365. PubMed ID: 30362635
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
[TBL] [Abstract][Full Text] [Related]
17. Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.
Guerriero I; D'Angelo D; Pallante P; Santos M; Scrima M; Malanga D; De Marco C; Ravo M; Weisz A; Laudanna C; Ceccarelli M; Falco G; Rizzuto A; Viglietto G
Oncotarget; 2017 Mar; 8(12):19172-19191. PubMed ID: 27880728
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MGC27382 inhibits proliferation and metastasis of non-small cell lung cancer cells via down-regulating AKT/GSK3β pathway.
Li Q; Li S; Niu L; Yang S; Niu H; Cheng C
Clin Transl Oncol; 2021 Dec; 23(12):2548-2559. PubMed ID: 34224057
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Shen WM; Yin JN; Xu RJ; Xu DF; Zheng SY
Kaohsiung J Med Sci; 2019 Jul; 35(7):401-407. PubMed ID: 31001918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
